Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France

François Montastruc; Charles Romano; Jean-Louis Montastruc; Stein Silva; Thierry Seguin; Vincent Minville; Bernard Georges; Béatrice Riu-Poulenc; Olivier Fourcade

doi:10.1016/j.therap.2020.05.005

Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France

Therapie. 2020 Jul-Aug;75(4):381-384. doi: 10.1016/j.therap.2020.05.005. Epub 2020 May 15.

Authors

François Montastruc¹, Charles Romano², Jean-Louis Montastruc³, Stein Silva², Thierry Seguin², Vincent Minville², Bernard Georges², Béatrice Riu-Poulenc², Olivier Fourcade²

Affiliations

¹ Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Toulouse University Hospital, Faculty of Medicine, 31000 Toulouse, France; Inserm, UMR 1027 Pharmacoepidemiology, Assessment of Drug Utilization and Drug Safety, CIC 1426 - University Paul-Sabatier, 31000 Toulouse, France. Electronic address: [email protected].
² Anestesia and Critical Care Medicine Department, Intensive Care Unit, Toulouse University Hospital, 31000 Toulouse, France.
³ Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Toulouse University Hospital, Faculty of Medicine, 31000 Toulouse, France; Inserm, UMR 1027 Pharmacoepidemiology, Assessment of Drug Utilization and Drug Safety, CIC 1426 - University Paul-Sabatier, 31000 Toulouse, France.

No abstract available

Keywords: Angiotensin II receptor blockers; Angiotensin converting enzyme inhibitors; COVID-19; Drugs; Non-steroidal anti-inflammatory drugs; Renin-angiotensin-aldosterone system.

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
COVID-19
COVID-19 Drug Treatment
Coronavirus Infections / drug therapy*
Female
France
Humans
Intensive Care Units*
Male
Middle Aged
Pandemics
Pneumonia, Viral / drug therapy*
Young Adult